US · Healthcare · Medical Devices
EPS came in at 0.07 against a street estimate of 0.10 — a miss of 30.0%.
Analysts rate Viemed Healthcare Inc a buy (1 buy, 1 hold, 0 sell out of 2) with an average price target of $12.50.
| Fund | Stake |
|---|---|
| BlackRock Inc | 12.57% |
| Forager Capital Management, LLC | 5.62% |
| Vanguard Capital Management, LLC | 3.47% |
| Nantahala Capital Management, LLC | 3.32% |
| The Goldman Sachs Group Inc | 3.21% |
| Arnhold & S. Bleichroeder Advisers, LLC | 2.81% |
| Ameriprise Financial Inc | 2.64% |
| Geode Capital Management, LLC | 2.56% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Viemed Healthcare Inc — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-18.